Palantir will soon help the FDA evaluate drugs, including COVID-19 treatments (Q5073)
Jump to navigation
Jump to search
No description defined
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Palantir will soon help the FDA evaluate drugs, including COVID-19 treatments
|
No description defined
|
Statements
8 December 2020
0 references